| Tag | Content |
|---|
EnhancerAtlas ID | HS162-02345 |
Organism | Homo sapiens |
Tissue/cell | Plasma_cell_myeloma |
Coordinate | chr12:27022560-27024580 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| MEF2C | MA0497.1 | chr12:27023563-27023578 | TTGCCAAAAATAGAT | + | 6.82 | | Myod1 | MA0499.1 | chr12:27023247-27023260 | GGGAACAGCTGCC | - | 6.24 | | Nr2f6(var.2) | MA0728.1 | chr12:27023016-27023031 | TGACCCCTTGACCTC | - | 6.97 | | RARA | MA0729.1 | chr12:27023013-27023031 | GACTGACCCCTTGACCTC | - | 6.06 | | Spz1 | MA0111.1 | chr12:27023639-27023650 | AGGGTATCAGC | + | 6.32 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_39536 | chr12:27022412-27024309 | Jurkat | | SE_49925 | chr12:27021331-27028563 | RPMI-8402 | | SE_66626 | chr12:27022412-27024309 | Jurkat |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH12I026870 | chr12 | 27023134 | 27024770 |
|
Enhancer Sequence | CAAAACAGTT CCACTCGGTG GGGGACTTAT GATATTATTT TTAATTTACA ACTTACATAG 60
ATTGGACTAC ATTCATCCCA GTAGTTCTAC CTAATAGTGA CACCAAAAGT CTGATCCTAG 120
AGTCAGACTA GAATCAATTC GATGGGAATA ATACGACTGG GGCACCTTCC AAAGTAGTTT 180
CTCAGGTCTT TTGGCACCAG TATCTCTCTG AAAACTGTAA GACACTACGT AAGTGTGAAA 240
GAAAATGCTA GAGCCAGTGT GGTGGAGTGG TTAAGAGCAG ATTTATCAGC CTCAGTTCAG 300
ATCCTGGTTC TGCCACTTCC CAGCTCCTTG AATGTGGGCC CATGGCTCAG CCTCTCTGTG 360
CCTCACTTCC TTCATGGGCT GATTATTCTC GGTGTGCCTT TAGGCCCTGT ACTGAGCCCT 420
CTGGGGACTG ACACATCAAG CCTGTATCAC CTGGACTGAC CCCTTGACCT CAGGCTTTTG 480
GTTGTTTCAG CCAATGGGAA ACGGGAAGGA AACAGGAAAG AGAGAGCAGT CAGCGTTTCC 540
CTCACTCCTC ACCTGCCCAC ACACCACTGG GGCTCTGGCC ACATCCCTCT AGACACAGAC 600
AGCTCCGCAG AGCTGCCCTT CCTACAGCAG CTCCTCATCA GGCTCCGGTT ACACGAGGTC 660
CTTGGCTTGC CCCTTCTGCC CAGGGCTGGG AACAGCTGCC CACTGCTGCT GGTTTCCTGG 720
ATGCCTCCCC ATCCCTCATG GATTCACTTA AATCTACCTA CTCATCTGTA AATAGTCCCT 780
TCCTTAAATT CTCTTCAGAA TTCCACCTGT GTGACCCCTG TCTCTTGCCT TGACAAACAC 840
ACTGCCTGGA GCTGTACTGA GGATTAAATA AACTAATATG TATTATAAAG CACTCAGAAC 900
AGCACAGCAC ACAGATTCAA TGCTATCTGC AGATGAGCTG TTGTTATCAG TAAGGTTGCC 960
CTGCCTGCCT TTCCTATCAG TACTGGAAGA CACACCTCTG AGATTGCCAA AAATAGATAA 1020
AGGCCCTATT TCTAGAGAGC CTCGGATGTC CGGAGAGCCT CTACCAGCCT CCCTACCTAA 1080
GGGTATCAGC ACAGGCTTGG ACAGGAAAGC TAGAGTGAAA CTGGCTTCGA TATAAATGGG 1140
AAAAGCCACC CCAGGCTGGG GCAAGGGAGG GGCAAAAGCA GGGCTCTCAA CAAGCCCACA 1200
GCTGAAGGAC TCAGTTCCTC TGGCAAGACT TGGGCTCCAG GAATTGAAAG GTGAGCAGTC 1260
TTTGGTTGAT AGGATCTTTA GAGGGTATGG CAACGTGCAG AGGAGGATAA AATGTCCCAG 1320
ACACACTTCC TTTACTTCAC AACTTGGCCC AGGGCCAGCC TGGCTATTTC CCACGTTCTA 1380
AAGCCCAGGT GGACCTAAGT GTTTGGAACT AAAATGATCT TATCTAAAAA AGAGCCAGCT 1440
GGCAGAATTC ACACACACAT ATTTAATTCT GATGAAAGCT GTTTCAGGCA GGAACCAAGA 1500
CCATTCTTTA TCAACAGGAC CGAGGGCATA TGCAGAGGAT CAAGAGGATG TAGTGGTTGA 1560
AAGTAAAGGC TCTCTGGGTA GACTGCCAAG ATTCAAAATC GGCTCCACTA CTTTCTAGCT 1620
GTGCAGCTTT CGCAAGTCAC TCAGACTCTC TAAGCCTCAC ATTTTTAGCC TGTAAAAATG 1680
GGCTGGGCGT AGTGACTCAC ACCTGTAATC CCAGCAGTTT GGGAGGCTGA GGTGGGAGGA 1740
ATGCTTGAGC CCCGGAGTGC AAGATCAGCC TGGGCAACAT GGCGAGACCC CATCTCTACA 1800
AAACTAAAAA ATTAGCTGGG CATGGTGGGT TCCAGCTACT CGGGAGGCTA AGGTGGGAGA 1860
ATCACTTGAG CCCAGGAGGT CAAGGTTGCA GTGAGCCATG ATTGTGCCAC TGCACTCCAG 1920
CCTGGGTGAC AGAGCAAGAC TGTGTCTCAA AAAAAAAAAA AAAAATGTTA GTAACAGACA 1980
CTACCATTAT AGTGATTACG AGAACTAAAT AAGGAAATTT 2020
|
